Concepedia

James R. Vasselli

JR

Statistics

Publications

27

Citations

4.7K

H-Index

22

Active since

1997

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

MacroGenics (United States)

University of Pennsylvania

James R. Vasselli is an author at National Cancer Institute specializing in medicine, tumor biology, and radiation oncology.

Top concepts

Publications per year

1997–2016

27

Publications

27

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Samuel A. Wells, Bruce G. Robinson, Robert F. Gagel et al. · Journal of Clinical Oncology · 2011 · 1.5K citations · Full text

Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Samuel A. Wells, Jessica E. Gosnell, Robert F. Gagel et al. · Journal of Clinical Oncology · 2010 · 513 citations · Full text

The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma

Jodi K. Maranchie, James R. Vasselli, Joseph Riss et al. · Cancer Cell · 2002 · 434 citations · Full text

, , +10

Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Bruce G. Robinson, Luis Paz‐Ares, Annetta Krebs et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 254 citations · Full text

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

John V. Heymach, Luis Paz‐Ares, Filippo de Braud et al. · Journal of Clinical Oncology · 2008 · 219 citations

1–5 of 27